R&D expenditure of the major CROs in China 2017-2019
In 2019, the Chinese drug manufacturer WuXi AppTec spent 590 million yuan on research and development. As the Chinese government has planned to enhance the pharmaceutical industry, the R&D spending has been increasing among the major contract research organizations in the country.